Polydex Pharmaceuticals (OTCMKTS:POLXF) Stock Passes Above 50-Day Moving Average of $1.98

Polydex Pharmaceuticals Limited (OTCMKTS:POLXFGet Free Report)’s share price crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $1.98 and traded as high as $1.99. Polydex Pharmaceuticals shares last traded at $1.99, with a volume of 2,000 shares.

Polydex Pharmaceuticals Trading Up 0.3 %

The company has a market capitalization of $6.81 million, a price-to-earnings ratio of -8.27 and a beta of 0.46. The stock’s fifty day simple moving average is $1.98 and its 200-day simple moving average is $1.50.

Polydex Pharmaceuticals (OTCMKTS:POLXFGet Free Report) last posted its quarterly earnings results on Thursday, June 15th. The company reported ($0.04) earnings per share (EPS) for the quarter. The company had revenue of $1.50 million during the quarter. Polydex Pharmaceuticals had a negative net margin of 17.77% and a negative return on equity of 16.50%.

About Polydex Pharmaceuticals

(Get Free Report)

Polydex Pharmaceuticals Ltd. is a development stage company, which engages in manufacturing of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry, and the development, manufacturing, and marketing of biotechnology-based products for the human pharmaceutical market.

Recommended Stories

Receive News & Ratings for Polydex Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polydex Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.